Edwards Lifesciences EW
NYSE EW
$88.08 +1.25 (+1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2009 - 2026)

Updated

Edwards Lifesciences (EW) recorded Net Income towards Common Stockholders of $241.9 million in Q2 2026, down 27.4% from $333.2 million a year earlier and down 36.5% from the prior quarter.

Analysis

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a TTM basis, Edwards Lifesciences' Net Income towards Common Stockholders came in at $1 billion as of Jun 30, 2026, down 75.8% year-over-year; for FY2025, it came in at $1.07 billion, down 74.3% from FY2024.

  • Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
  • Across earlier years, Net Income towards Common Stockholders came in at $4.17 billion in FY2024 (+197.7%), $1.4 billion in FY2023 (-7.9%), $1.52 billion in FY2022 (+1.3%) and $1.5 billion in FY2021 (+82.5%).
  • Quarterly Net Income towards Common Stockholders has ranged from $91.2 million in Q4 2025 to $3.07 billion in Q3 2024 over the past five years.
  • On a year-over-year basis, Net Income towards Common Stockholders rose in four of the last eight quarters, with growth averaging 63.4%.
  • Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 697.8% in Q3 2024, against a decline of 90.5% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $380.7 million (Q1 2026), $91.2 million (Q4 2025) and $291.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 1.74 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 928.00 Mn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 818.10 Mn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 1.47 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 1.28 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 907.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 377.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 241.90 Mn
10 Agilent Technologies 49.40 Bn 42.29 Bn 1.04 Bn 362.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 241.90 Mn
Mar 31, 2026 380.70 Mn
Dec 31, 2025 91.20 Mn
Sep 30, 2025 291.10 Mn
Jun 30, 2025 333.20 Mn
Mar 31, 2025 358.00 Mn
Dec 31, 2024 385.60 Mn
Sep 30, 2024 3.07 Bn
Jun 30, 2024 366.30 Mn
Mar 31, 2024 351.90 Mn
Dec 31, 2023 369.90 Mn
Sep 30, 2023 384.90 Mn
Jun 30, 2023 307.10 Mn
Mar 31, 2023 340.50 Mn
Dec 31, 2022 398.40 Mn
Sep 30, 2022 343.50 Mn
Jun 30, 2022 406.40 Mn
Mar 31, 2022 373.60 Mn
Dec 31, 2021 335.30 Mn
Sep 30, 2021 340.10 Mn
API Access

Edwards Lifesciences Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EW&period=max&api_key=YOUR_API_KEY